Publication | Open Access
The hybrid oncolytic peptide NTP-385 potently inhibits adherent cancer cells by targeting the nucleus
67
Citations
23
References
2022
Year
Tumor BiologyCancer ImmunosurveillanceMedicineAdherent Cancer CellsPeptide TherapeuticImmune Checkpoint InhibitorTumor SuppressorRadiation OncologyCancer BiologyCell BiologyCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1